F&P Healthcare warns of $5-10M hit in contesting latest Resmed patent allegations

F&P Healthcare warns of $5-10M hit in contesting latest Resmed patent allegations
Paul McBeth
By Paul McBeth Sept. 3 (BusinessDesk) - Fisher & Paykel Healthcare expects the cost of contesting the latest patent allegations from rival ResMed will cut annual earnings by as much as $10 million in a far-ranging dispute across multiple jurisdictions.  The Auckland-based maker of hospital equipment and personal sleep apnoea products will contest complaints in the US International Trade Commission (ITC) and US District Court for the Southern District of California, it said in a statement. F&P Healthcare cut forecast profit to $205 million...